SITUATION OF USE OF PROTON PUMP INHIBITORS

Hồng Ngọc Nguyễn, Đặng Phương Chi Bùi, Văn Mãi Đỗ

Main Article Content

Abstract

Objective: Assessing the use of proton pump inhibitors (PPI) at 120 Military Hospital in Tien Giang province. Subjects and methods: Cross-sectional descriptive study on 4532 outpatient prescriptions of patients who were prescribed drugs by doctors from July 1 st , 2020 to July 30 th , 2020 at clinics of the examination department - Military Hospital 120. Results: The highest percentage of patients indicated to use proton pump inhibitors was the group of patients in working age from 20 - 60 years old, accounting for 62.16%. The percentage of female patients accounted for much higher than male patients, respectively 62.35% and 37.65%. The most indicated proton pump inhibitors were omeprazole at the rate of 60.06%, followed by Pantoprazole at the rate of 21.89%, proton pump inhibitors with the lowest percentage were Rabeprazole at the rate of 0.88%. For gastroesophageal reflux disease, gastroenteritis prevention, proton pump inhibitors were widely used as omeprazole. The drugs omeprazole, pantoprazole and esomeprazole all had a predominant ratio of 40mg doses. Conclusion: The prevalence of PPIs indicated for use was mainly female, aged 20-60 years old. The most commonly prescribed drug was omeprazole with a dose of 40mg in the most common group of diseases was gastroesophageal reflux disease, prevention of gastroenteritis.

Article Details

References

1. Bộ Y tế (2006), Tương tác thuốc và chú ý khi chỉ định, NXB Y học.
2. http://www.mims.com/vietnam/drug/info/acilesol.
3. Bộ môn Nội - Đại học Y Dược Huế (2009). Viêm dạ dày, Giáo trình sau đại học Bệnh Tiêu hóa Gan mật:
153-169.
4. Bùi Mai Nguyệt Ánh (2013). Khảo sát tình hình sử dụng thuốc ức chế bơm proton trong kê đơn thuốc Bảo hiểm
y tế ngoại trú tại Bệnh viện đa khoa Thống Nhất Đồng Nai năm 2013.
5. Mai Nguyệt Ánh (2011). So sánh hiệu quả điều trị viêm loét DD-TT do nhiễm HP giữa hai phác đồ PAL và
PAC tại bệnh viện ĐK Đồng Nai.
6. Pankaj Jay Pasricha Willemlintje A Hoogerwerf (2005). Pharmacotheraphy of gastric acidity, peptid ulcers and
gastroesophageal reflux disease. Goodman & Gilmans The Pharmacological basis of therapeutics.eleventh edition, Mr
Graw Hill: 967-982.
7. Ahmed Yacoob Mayet (2007). Improper use of antisecretory drugs in a tertiary care teaching hospital: An
observational study. The Saudi Journal of Gastroenterology, 13(3): 124-128.
8. John Del Valle (2009). Zollinger-Ellison syndrome Texbook of Gastroenterology, fifth edition. Wiley
Blackwell, 1: 982-988.
9. Mandel KG, Dadgy BP, Brodie DA (2000). Review article alginateraft formoulations in the treatment of
heartbum ang acid reflux, Aliment Pharmacol Ther14(6): 669-690.